• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。

Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.

机构信息

Department of Vascular Medicine, Vascular Center, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Shibukawa, Gunma, Japan.

Department of Vascular Medicine, Vascular Center, Cardiovascular Hospital of Central Japan (Kitakanto Cardiovascular Hospital), Shibukawa, Gunma, Japan

出版信息

Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.

DOI:10.1093/ehjci/jev338
PMID:26758409
Abstract

AIMS

Lipoprotein(a) (Lp(a)) levels have been associated with aortic valvular calcification and stenosis. The prevalence and risk factors, including Lp(a) level, for valvular heart disease (VHD) were investigated in patients with peripheral arterial disease (PAD).

METHODS AND RESULTS

Echocardiography was performed in 861 patients with PAD to detect abnormal cardiac findings. Relationships between VHD and risk factors were analysed. The prevalence of VHD was 43.6%, and the prevalences of aortic valve regurgitation (AR), mitral valve regurgitation (MR), aortic valve stenosis (AS), mitral valve stenosis (MS), and tricuspid regurgitation (TR) were 26.8, 19.7, 5.9, 1.3, and 9.4%, respectively. In stepwise multiple regression analysis, severity of AR was related to age, albumin, and estimated glomerular filtration rate (eGFR); MR was related to eGFR and age; AS was related to eGFR, Lp(a), and age; MS was related to Lp(a) and female gender; and TR was related to age, body mass index, and total cholesterol (all P < 0.05). Lp(a) level was higher in patients with AS compared with those without AS [34.0 (16.7-50.0) vs. 20.0 (11.0-35.0) mg/dL, P = 0.002], in patients with MS compared with those without MS [37.0 (21.5-77.3) vs. 21.0 (11.0-35.0), P = 0.037], and in patients with AS and/or MS compared with those without AS and MS [34.0 (17.3-50.0) vs. 20.0 (11.0-35.0), P = 0.001]. Lp(a) levels were related to low-density lipoprotein cholesterol and high-sensitivity C-reactive protein levels (P = 0.004).

CONCLUSIONS

The high prevalence of VHD is found, especially in AR and MR, and the Lp(a) level is associated with increased risks of AS and MS in patients with PAD.

摘要

目的

脂蛋白(a)(Lp(a))水平与主动脉瓣钙化和狭窄有关。本研究旨在探讨外周动脉疾病(PAD)患者中瓣膜性心脏病(VHD)的患病率和危险因素,包括 Lp(a)水平。

方法和结果

对 861 例 PAD 患者进行超声心动图检查,以检测异常心脏发现。分析 VHD 与危险因素之间的关系。VHD 的患病率为 43.6%,主动脉瓣反流(AR)、二尖瓣反流(MR)、主动脉瓣狭窄(AS)、二尖瓣狭窄(MS)和三尖瓣反流(TR)的患病率分别为 26.8%、19.7%、5.9%、1.3%和 9.4%。逐步多元回归分析显示,严重 AR 与年龄、白蛋白和估算肾小球滤过率(eGFR)有关;MR 与 eGFR 和年龄有关;AS 与 eGFR、Lp(a)和年龄有关;MS 与 Lp(a)和女性有关;TR 与年龄、体重指数和总胆固醇有关(均 P < 0.05)。与无 AS 患者相比,AS 患者的 Lp(a)水平更高[34.0(16.7-50.0)比 20.0(11.0-35.0)mg/dL,P = 0.002],MS 患者的 Lp(a)水平更高[37.0(21.5-77.3)比 21.0(11.0-35.0)mg/dL,P = 0.037],AS 和/或 MS 患者的 Lp(a)水平更高[34.0(17.3-50.0)比 20.0(11.0-35.0)mg/dL,P = 0.001]。Lp(a)水平与低密度脂蛋白胆固醇和高敏 C 反应蛋白水平相关(P = 0.004)。

结论

PAD 患者中 VHD 的高患病率,尤其是 AR 和 MR,且 Lp(a)水平与 AS 和 MS 风险增加有关。

相似文献

1
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.
2
Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.经导管主动脉瓣置换术后主动脉瓣反流患者 1 年死亡率的预测因素:来自多中心德国 TAVI 登记处的分析。
Heart. 2014 Aug;100(16):1250-6. doi: 10.1136/heartjnl-2013-305385. Epub 2014 Jun 3.
3
High-sensitivity C-reactive Protein, Lipoprotein(a) and Homocysteine are Risk Factors for Coronary Artery Disease in Japanese Patients with Peripheral Arterial Disease.高敏C反应蛋白、脂蛋白(a)和同型半胱氨酸是日本外周动脉疾病患者冠状动脉疾病的危险因素。
J Atheroscler Thromb. 2015;22(4):344-54. doi: 10.5551/jat.25478. Epub 2014 Oct 8.
4
Valvular Heart Disease in Adults: Etiologies, Classification, and Diagnosis.成人心脏瓣膜病:病因、分类及诊断
FP Essent. 2017 Jun;457:11-16.
5
Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.脂蛋白(a)水平与家族性高胆固醇血症无症状患者的主动脉瓣钙化有关。
J Intern Med. 2015 Aug;278(2):166-73. doi: 10.1111/joim.12335. Epub 2015 Jan 5.
6
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病与心脏瓣膜病:改善全球肾脏病预后组织(KDIGO)争议会议的结论。
Kidney Int. 2019 Oct;96(4):836-849. doi: 10.1016/j.kint.2019.06.025.
7
Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.载脂蛋白(a)和 LPA KIV2 重复多态性在二叶式主动脉瓣狭窄和钙化中的作用:概念验证研究。
Intern Emerg Med. 2019 Jan;14(1):45-50. doi: 10.1007/s11739-018-1925-8. Epub 2018 Aug 11.
8
Comparison of Lipoprotein(a)-Levels in Patients ≥70 Years of Age With Versus Without Aortic Valve Stenosis.70岁及以上有与无主动脉瓣狭窄患者脂蛋白(a)水平的比较。
Am J Cardiol. 2018 Aug 15;122(4):645-649. doi: 10.1016/j.amjcard.2018.04.046. Epub 2018 May 11.
9
Identifying People at High Risk for Severe Aortic Stenosis: Aortic Valve Calcium Versus Lipoprotein(a) and Low-Density Lipoprotein Cholesterol.确定主动脉瓣狭窄高危人群:主动脉瓣钙化与脂蛋白(a)和低密度脂蛋白胆固醇。
Circ Cardiovasc Imaging. 2024 Jun;17(6):e016372. doi: 10.1161/CIRCIMAGING.123.016372. Epub 2024 Jun 18.
10
Coronary artery disease is associated with valvular heart disease, but could it Be a predictive factor?冠状动脉疾病与心脏瓣膜病相关,但它会是一个预测因素吗?
Indian Heart J. 2019 May-Jun;71(3):284-287. doi: 10.1016/j.ihj.2019.07.001. Epub 2019 Jul 6.

引用本文的文献

1
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
2
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option.脂蛋白(a):心血管疾病、主动脉瓣狭窄和新的治疗选择。
Int J Mol Sci. 2022 Dec 22;24(1):170. doi: 10.3390/ijms24010170.
3
Lipoprotein(a) is a Promising Residual Risk Factor for Long-Term Clinical Prognosis in Peripheral Arterial Disease.
脂蛋白(a)是外周动脉疾病长期临床预后的一个有前景的残余危险因素。
Ann Vasc Dis. 2022 Sep 25;15(3):186-192. doi: 10.3400/avd.oa.22-00046.
4
Value of the systemic immune-inflammation index in predicting poor postoperative outcomes and the short-term prognosis of heart valve diseases: a retrospective cohort study.系统性免疫炎症指数在预测心脏瓣膜病术后不良结局和短期预后中的价值:一项回顾性队列研究。
BMJ Open. 2022 Oct 11;12(10):e064171. doi: 10.1136/bmjopen-2022-064171.
5
A case of hyperlipoprotein(a)emia undergoing catheter interventions for coronary artery disease, aortic valve stenosis, and peripheral artery disease.一例患有高脂蛋白(a)血症的患者接受了针对冠状动脉疾病、主动脉瓣狭窄和外周动脉疾病的导管介入治疗。
SAGE Open Med Case Rep. 2022 Feb 7;10:2050313X221074464. doi: 10.1177/2050313X221074464. eCollection 2022.
6
Influence of Microalbuminuria on Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease.微量白蛋白尿对周围动脉疾病患者长期生存及心血管或肢体事件的影响
Ann Vasc Dis. 2021 Sep 25;14(3):236-243. doi: 10.3400/avd.oa.21-00045.
7
Lipoprotein (a) and risk for calcification of the coronary arteries, mitral valve, and thoracic aorta: The Multi-Ethnic Study of Atherosclerosis.脂蛋白(a)与冠状动脉、二尖瓣和胸主动脉钙化风险的关系:动脉粥样硬化的多民族研究。
J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):154-160. doi: 10.1016/j.jcct.2020.06.002. Epub 2020 Jun 21.
8
Aortic Valve Regurgitation: Pathophysiology and Implications for Surgical Intervention in the Era of TAVR.主动脉瓣反流:经导管主动脉瓣置换术时代的病理生理学及外科干预意义
Struct Heart. 2020;4(2):87-98. doi: 10.1080/24748706.2020.1719446. Epub 2020 Jan 23.
9
Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification.脂蛋白(a)基因多态性增加主动脉瓣钙化的危险因素。
J Cardiovasc Dev Dis. 2019 Aug 26;6(3):31. doi: 10.3390/jcdd6030031.
10
The Geriatric Nutritional Risk Index Predicts Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease.老年营养风险指数预测外周动脉疾病患者的长期生存和心血管或肢体事件。
J Atheroscler Thromb. 2020 Feb 1;27(2):134-143. doi: 10.5551/jat.49767. Epub 2019 Jun 19.